Stock listing
NASDAQ:RSLS ReShape Lifesciences Inc Stock
Follow ReShape Lifesciences Inc into a list and get an email when it puts out news.
Delisted NASDAQ:RSLS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RSLS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
ReShape Lifesciences Inc on 6ix
- Decks
- 8 decks · latest Jan 31, 2018
Where ReShape Lifesciences Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RSLS · This page · Delisted | NASDAQ | United States | USD |
| OTC:RSLSD · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2018) | Investor deck | 26 slides | Jan 31, 2018 |
| EnteroMedics — Investor Presentation (July 2017) | Investor deck | 27 slides | Jul 26, 2017 |
| EnteroMedics — IPO Roadshow (December 2016) | IPO roadshow | 31 slides | Dec 30, 2016 |
| EnteroMedics — Technical Presentation (February 2013) | Technical | 13 slides | Feb 8, 2013 |
| EnteroMedics — Technical Presentation (November 2012) | Technical | 10 slides | Nov 13, 2012 |
| EnteroMedics — Canaccord Genuity Presentation (August 2011) | Conference | 25 slides | Aug 11, 2011 |
| EnteroMedics — IPO Roadshow (November 2010) | IPO roadshow | 22 slides | Nov 23, 2010 |
| EnteroMedics — Technical Presentation (November 2009) | Technical | 7 slides | Nov 12, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Barton P Bandy Other companies: Vyome Holdings, Inc. (President and CEO, Director · Jun 15, 2021 – Aug 5, 2022 · Past) | President and CEO · Apr 1, 2019 – Apr 1, 2019 · Past |
| Dan W Gladney Other companies: Vyome Holdings, Inc. (Director · Jun 15, 2021 – Jul 22, 2021 · Past) | Chairman, President and CEO, Director · Oct 28, 2015 – Apr 18, 2018 · Past |
| Mark B Knudson Other companies: Restore Medical Inc (Director · Dec 31, 2007 – Jul 16, 2008 · Past) | Director · Nov 14, 2007 – May 4, 2016 · Past |
| Nicholas Teti Other companies: Fibrocell Science Inc (Director · Jun 5, 2006 – Dec 31, 2007 · Past) | Director · Nov 14, 2007 – Feb 8, 2017 · Past |
| Paul F. Hickey Other companies: Vyome Holdings, Inc. (President and Chief Executive Officer · Aug 15, 2022 – Nov 4, 2026 · Past) | SVP of Mktg & Reimb · Jan 18, 2016 – Feb 8, 2017 · Past |
| Thomas Stankovich Other companies: Vyome Holdings, Inc. (Chief Financial Officer · Jun 15, 2021 – Nov 30, 2023 · Past) | Chief Financial Officer · Oct 30, 2019 – Jun 15, 2021 · Past |
| Adrianus Donders | Sr VP of Research & Adv Dev · Oct 29, 2010 – Mar 9, 2015 · Past |
| Amy L Scott | VP, Marketing & Patient Access · Nov 8, 2017 – Nov 8, 2017 · Past |
| Anthony P Jansz | Director · May 5, 2011 – May 4, 2016 · Past |
| Katherine S Tweden | VP - Clinical and Regulatory · Mar 10, 2011 – Mar 9, 2015 · Past |
All 12 people
| Person | Seat |
|---|---|
| Rajesh Nihalani | Chief Technology Officer · May 22, 2017 – May 22, 2017 · Past |
| Scott A Shikora | EVP & Chief Medical Officer · Jun 1, 2015 – Jun 27, 2016 · Past |
Log in to ask 6ix AI your own questions about ReShape Lifesciences Inc.